63.58
前日終値:
$63.02
開ける:
$62.45
24時間の取引高:
191.03K
Relative Volume:
0.22
時価総額:
$3.17B
収益:
$1.36B
当期純損益:
$123.81M
株価収益率:
26.38
EPS:
2.41
ネットキャッシュフロー:
$20.35M
1週間 パフォーマンス:
-1.19%
1か月 パフォーマンス:
-3.08%
6か月 パフォーマンス:
-19.95%
1年 パフォーマンス:
-24.58%
Haemonetics Corp Stock (HAE) Company Profile
HAE を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
HAE
Haemonetics Corp
|
63.52 | 3.17B | 1.36B | 123.81M | 20.35M | 2.41 |
![]()
ABT
Abbott Laboratories
|
131.32 | 225.32B | 41.95B | 13.40B | 6.35B | 7.65 |
![]()
BSX
Boston Scientific Corp
|
100.00 | 149.74B | 16.75B | 1.85B | 2.37B | 1.25 |
![]()
SYK
Stryker Corp
|
376.17 | 142.48B | 22.60B | 2.99B | 3.49B | 7.76 |
![]()
MDT
Medtronic Plc
|
88.45 | 113.49B | 33.20B | 4.26B | 5.47B | 3.29 |
![]()
EW
Edwards Lifesciences Corp
|
71.78 | 42.10B | 5.72B | 4.17B | 259.90M | 6.97 |
Haemonetics Corp Stock (HAE) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-02-07 | ダウングレード | BofA Securities | Neutral → Underperform |
2024-12-06 | 開始されました | JP Morgan | Overweight |
2024-11-08 | アップグレード | Raymond James | Outperform → Strong Buy |
2024-09-13 | 開始されました | CL King | Buy |
2024-09-11 | 開始されました | BofA Securities | Neutral |
2024-09-10 | 開始されました | BTIG Research | Buy |
2024-06-12 | アップグレード | Needham | Hold → Buy |
2022-10-13 | 開始されました | Mizuho | Buy |
2022-01-27 | ダウングレード | Needham | Buy → Hold |
2021-12-15 | ダウングレード | Citigroup | Buy → Neutral |
2021-08-17 | 再開されました | Raymond James | Outperform |
2021-06-17 | 開始されました | Citigroup | Buy |
2021-05-14 | アップグレード | CJS Securities | Market Perform → Market Outperform |
2021-04-20 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
2021-04-19 | ダウングレード | CJS Securities | Market Outperform → Market Perform |
2021-02-03 | アップグレード | Barrington Research | Mkt Perform → Outperform |
2021-01-21 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
2020-11-05 | アップグレード | Barrington Research | Mkt Perform → Outperform |
2020-05-06 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
2020-03-31 | アップグレード | CJS Securities | Market Perform → Market Outperform |
2020-01-10 | 開始されました | Needham | Buy |
2019-08-07 | 繰り返されました | Barrington Research | Outperform |
2019-05-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
2019-05-08 | 繰り返されました | Barrington Research | Outperform |
2018-08-09 | 繰り返されました | Barrington Research | Outperform |
2018-02-07 | 繰り返されました | Barrington Research | Outperform |
2018-01-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
2017-11-08 | 繰り返されました | Barrington Research | Outperform |
2017-08-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
2017-07-13 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
2017-02-07 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
2016-11-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
2016-11-07 | 繰り返されました | The Benchmark Company | Hold |
2016-09-20 | ダウングレード | CJS Securities | Market Outperform → Market Perform |
2016-08-15 | ダウングレード | Sidoti | Buy → Neutral |
2016-08-02 | 繰り返されました | Jefferies | Buy |
2016-08-02 | 繰り返されました | The Benchmark Company | Hold |
すべてを表示
Haemonetics Corp (HAE) 最新ニュース
Haemonetics Corp. (HAE): Among the 10 Pro-Life Companies to Invest In Now? - Yahoo Finance
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2025 Results: May 8, 2025 - Yahoo Finance
10 Pro-Life Companies to Invest In Now - Insider Monkey
A Note On Haemonetics Corporation's (NYSE:HAE) ROE and Debt To Equity - Yahoo Finance
Fractional Flow Reserve Market Set for 11.27% CAGR Growth by 2031 - openPR
Haemonetics (NYSE:HAE) Given New $104.00 Price Target at Needham & Company LLC - Defense World
Is it Apt to Retain HAE Stock in Your Portfolio for Now? - Nasdaq
Demystifying Haemonetics: Insights From 5 Analyst Reviews - Nasdaq
Needham Trims Price Target on Haemonetics to $104 From $108, Keeps Buy Rating -March 18, 2025 at 06:53 am EDT - MarketScreener
Haemonetics FY2025 EPS Estimate Reduced by Zacks Research - Defense World
Haemonetics Corp (HAE) Shares Down 3.63% on Mar 12 - GuruFocus.com
How Do Investors Really Feel About Haemonetics? - Benzinga
Haemonetics at Raymond James Conference: Strategic Growth Insights - Investing.com
Haemonetics at Raymond James Conference: Strategic Growth Insights By Investing.com - Investing.com UK
Haemonetics Names Chief Operating Officer, Chief Commercial Officer -March 03, 2025 at 05:40 pm EST - Marketscreener.com
Haemonetics appoints new executive leadershi - Investing.com
Haemonetics Announces Executive Leadership Updates - Quantisnow
Global Blood Bank Market to Register Immense Growth at a CAGR of ~7% by 2032 | DelveInsight - GlobeNewswire Inc.
Haemonetics Corp. to Host Earnings Call - ACCESS Newswire
Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference - Quantisnow
Zacks Research Forecasts Haemonetics’ Q3 Earnings (NYSE:HAE) - Defense World
Van ECK Associates Corp Buys Shares of 39,620 Haemonetics Co. (NYSE:HAE) - Defense World
Haemonetics FY2025 EPS Forecast Decreased by Zacks Research - Defense World
(HAE)Analyzing Haemonetics's Short Interest - Benzinga
SG Americas Securities LLC Decreases Stock Holdings in Haemonetics Co. (NYSE:HAE) - MarketBeat
Janney Montgomery Scott LLC Invests $402,000 in Haemonetics Co. (NYSE:HAE) - MarketBeat
Haemonetics (NYSE:HAE) Reaches New 12-Month Low After Analyst Downgrade - MarketBeat
Haemonetics Co. (NYSE:HAE) Given Consensus Rating of “Moderate Buy” by Brokerages - Armenian Reporter
Haemonetics Co. (NYSE:HAE) Shares Sold by Retirement Systems of Alabama - MarketBeat
Haemonetics Co. (NYSE:HAE) Shares Sold by Yousif Capital Management LLC - Defense World
Haemonetics' (NYSE:HAE) Earnings Offer More Than Meets The Eye - Yahoo Finance
Haemonetics Co. (NYSE:HAE) Receives $101.67 Average Price Target from Analysts - MarketBeat
Haemonetics (NYSE:HAE) Given New $108.00 Price Target at Needham & Company LLC - MarketBeat
Haemonetics Co. (NYSE:HAE) Receives $101.67 Consensus Target Price from Analysts - Defense World
Haemonetics (NYSE:HAE) Price Target Cut to $100.00 by Analysts at JMP Securities - MarketBeat
Haemonetics (NYSE:HAE) Raised to "Buy" at StockNews.com - MarketBeat
Haemonetics (NYSE:HAE) Downgraded to Underperform Rating by Bank of America - MarketBeat
Haemonetics' (HAE) "Strong-Buy" Rating Reaffirmed at Raymond James - MarketBeat
Haemonetics (NYSE:HAE) Reaches New 52-Week Low After Analyst Downgrade - Defense World
Barrington Research Issues Pessimistic Forecast for Haemonetics (NYSE:HAE) Stock Price - MarketBeat
Haemonetics’ (HAE) “Strong-Buy” Rating Reiterated at Raymond James - Defense World
Haemonetics (NYSE:HAE) Upgraded at StockNews.com - Defense World
Haemonetics (NYSE:HAE) Shares Gap Down Following Weak Earnings - MarketBeat
It is Poised to be a Bull Market for Haemonetics Corp (HAE) - SETE News
Haemonetics (HAE) Projected to Post Earnings on Thursday - MarketBeat
Haemonetics (NYSE:HAE) Releases FY 2025 Earnings Guidance - MarketBeat
Haemonetics (NYSE:HAE) Receives “Strong-Buy” Rating from Raymond James - Armenian Reporter
Haemonetics Co. (NYSE:HAE) Sees Large Increase in Short Interest - MarketBeat
Haemonetics (HAE) Q3 Earnings Meet Estimates - MSN
Haemonetics Corp [HAE] Former Officer makes an insider purchase of 6,238 shares worth 0.57 million. - Knox Daily
Haemonetics' stock slides on revenue miss - MSN
Haemonetics Corp (HAE) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):